Stoke Therapeutics, Inc. (STOK) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: STOK) | Delayed: 26.35 +0.67 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.68 | 52 Week High | $ | |||
| Open | $25.88 | 52 Week Low | $ | |||
| Day High | $26.72 | P/E | N/A | |||
| Day Low | $25.69 | EPS | $ | |||
| Volume | 208,890 | |||||
